Login

V-Cube Revolutionizes Virtual Collaboration Through Integration with Zoom Platform | Kazunori Yahata At V-cube Inc 00:10:00

Share On Facebook Share On Twitter

V-cube Inc. - New Business Development

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Insights from Industrial Real Estate: Quickfire Q&A with Segro's CFO
00:10:00
Own capital is able to define and implement its own long-term strategic goals|Robert R. Dyson, Chairman,The Dyson-Kissner-Moran Corporation
00:10:00
Downing Estate Drilling Celebrates 80-Year Legacy with Boart Longyear
00:10:00
Understanding Bonds: Coupon, Current Yield, and Yield to Maturity Explained | Charity DiCola - FIXED INCOME ANALYST of Howe & Rusling, Inc.
00:10:00
Focus on large markets and strong founder-market fit. He primarily invests in DTC|Andrew Gluck,General Partner, irrvrntVC
00:00:00
Hamilton Thorne brings its laser technology human fertility - David Wolf, President and CEO of Hamilton Thorne Ltd.
00:10:00
Amundi’s Strategic Shift Towards Sustainable and Net Zero Investments | Valérie Baudson, CEO, Amundi .
00:10:00
Achieving Financial Success with Michael McCoy | Michael McCoy, New Wealth Advisors Club
00:00:00
Kancera at Carlsquare Nordic Life Science Investor Day 6 Dec. 2023 - Peter Selin, CEO, Kancera
00:10:00
Unlocking Genetic Diversity: A Conversation with Richard Gabriel of DNA Print Genomics
00:00:00
Introduction to Surgical Leadership Program - Sayeed Malek, MD, FACS , Assistant Professor of Surgery, Harvard Medical School
00:10:00
Geoffrey Benic, CEO of Aleafia Health Inc., and Louis Laflamme, CEO of Opsens Inc., share insights in "The View From The C-Suite."

© 2017 - Neuhu+